Status:
COMPLETED
Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to evaluate efficacy and acceptability of the Chinese language version of MoodGYM as a therapeutic intervention in treating symptoms of depression in community dwelling Chinese America...
Eligibility Criteria
Inclusion
- Resident of the US, but self-identified as Chinese origin
- At least 18 years of age
- Proficiency in Chinese, including the ability to read Chinese
- Access to computer and internet
- Scores \> 10 on the Chinese bilingual patient health questionnaire -9 item (PHQ-9)
Exclusion
- Current ongoing psychiatric or psychological treatment
- Using illicit drugs or consumption \> 3 standard drinks in a day
- Currently experiencing a psychotic illness
- Past or current history of schizophrenia or bipolar disorder
- ECT during the last year
- Current active suicidal or self-injurious potential necessitating immediate face-to-face treatment
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2016
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT01851967
Start Date
September 1 2014
End Date
November 1 2016
Last Update
December 1 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital Depression Clinical and Research Program
Boston, Massachusetts, United States, 02114
2
Ying Wang
Beijing, China